Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma

Background: Head and neck squamous cell carcinoma (HNSCC) is one of the leading causes of cancer-related deaths and calls for new druggable targets. We have previously highlighted the critical role of ADP-ribosylation factor-1 (Arf1) activation in HNSCC. In the present study, we address the question...

Full description

Bibliographic Details
Main Authors: Yen Vo-Hoang, Sergio Paiva, Leilei He, Sébastien Estaran, Yong Teng
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/2/286
_version_ 1797724830153310208
author Yen Vo-Hoang
Sergio Paiva
Leilei He
Sébastien Estaran
Yong Teng
author_facet Yen Vo-Hoang
Sergio Paiva
Leilei He
Sébastien Estaran
Yong Teng
author_sort Yen Vo-Hoang
collection DOAJ
description Background: Head and neck squamous cell carcinoma (HNSCC) is one of the leading causes of cancer-related deaths and calls for new druggable targets. We have previously highlighted the critical role of ADP-ribosylation factor-1 (Arf1) activation in HNSCC. In the present study, we address the question whether targeting Arf1 could be proposed as a valuable strategy against HNSCC. Methods: We rationally designed and synthesized constrained ATC-based (4-amino-(methyl)-1,3-thiazole-5-carboxylic acid) γ-dipeptides to block Arf1 activation. We evaluated the effects of these γ-dipeptides in HNSCC cells: The cell viability was determined in 2D and 3D cell cultures after 72 h treatment and Arf1 protein levels and activity were assessed by GGA3 pull-down and Western blotting assays. Results: Targeting Arf1 offers a valuable strategy to counter HNSCC. Our new Arf1-targeting compounds revealed a strong in vitro cytotoxicity against HNSCC cells, through inhibiting Arf1 activation and its downstream pathways. Conclusions: Arf1-targeting γ-dipeptides developed in this study may represent a promising targeted therapeutic to improve managing the HNSCC disease.
first_indexed 2024-03-12T10:22:26Z
format Article
id doaj.art-333ff86a38694d73b36f50d9cc6a05a6
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T10:22:26Z
publishDate 2020-01-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-333ff86a38694d73b36f50d9cc6a05a62023-09-02T10:01:18ZengMDPI AGCells2073-44092020-01-019228610.3390/cells9020286cells9020286Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell CarcinomaYen Vo-Hoang0Sergio Paiva1Leilei He2Sébastien Estaran3Yong Teng4Institut des Biomolécules Max Mousseron, UMR 5247, CNRS-UM-ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, 15 avenue Charles Flahault, 34093 Montpellier CEDEX 5, FranceInstitut des Biomolécules Max Mousseron, UMR 5247, CNRS-UM-ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, 15 avenue Charles Flahault, 34093 Montpellier CEDEX 5, FranceDepartment of Oral Biology and Diagnostic Sciences, Georgia Cancer Center, Augusta University, 1120 15th Street, Augusta, GA 309212, USAInstitut des Biomolécules Max Mousseron, UMR 5247, CNRS-UM-ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, 15 avenue Charles Flahault, 34093 Montpellier CEDEX 5, FranceDepartment of Oral Biology and Diagnostic Sciences, Georgia Cancer Center, Augusta University, 1120 15th Street, Augusta, GA 309212, USABackground: Head and neck squamous cell carcinoma (HNSCC) is one of the leading causes of cancer-related deaths and calls for new druggable targets. We have previously highlighted the critical role of ADP-ribosylation factor-1 (Arf1) activation in HNSCC. In the present study, we address the question whether targeting Arf1 could be proposed as a valuable strategy against HNSCC. Methods: We rationally designed and synthesized constrained ATC-based (4-amino-(methyl)-1,3-thiazole-5-carboxylic acid) γ-dipeptides to block Arf1 activation. We evaluated the effects of these γ-dipeptides in HNSCC cells: The cell viability was determined in 2D and 3D cell cultures after 72 h treatment and Arf1 protein levels and activity were assessed by GGA3 pull-down and Western blotting assays. Results: Targeting Arf1 offers a valuable strategy to counter HNSCC. Our new Arf1-targeting compounds revealed a strong in vitro cytotoxicity against HNSCC cells, through inhibiting Arf1 activation and its downstream pathways. Conclusions: Arf1-targeting γ-dipeptides developed in this study may represent a promising targeted therapeutic to improve managing the HNSCC disease.https://www.mdpi.com/2073-4409/9/2/286hnsccarf1constrained γ-dipeptidesanticancer
spellingShingle Yen Vo-Hoang
Sergio Paiva
Leilei He
Sébastien Estaran
Yong Teng
Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma
Cells
hnscc
arf1
constrained γ-dipeptides
anticancer
title Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma
title_full Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma
title_fullStr Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma
title_full_unstemmed Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma
title_short Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma
title_sort design and synthesis of arf1 targeting γ dipeptides as potential agents against head and neck squamous cell carcinoma
topic hnscc
arf1
constrained γ-dipeptides
anticancer
url https://www.mdpi.com/2073-4409/9/2/286
work_keys_str_mv AT yenvohoang designandsynthesisofarf1targetinggdipeptidesaspotentialagentsagainstheadandnecksquamouscellcarcinoma
AT sergiopaiva designandsynthesisofarf1targetinggdipeptidesaspotentialagentsagainstheadandnecksquamouscellcarcinoma
AT leileihe designandsynthesisofarf1targetinggdipeptidesaspotentialagentsagainstheadandnecksquamouscellcarcinoma
AT sebastienestaran designandsynthesisofarf1targetinggdipeptidesaspotentialagentsagainstheadandnecksquamouscellcarcinoma
AT yongteng designandsynthesisofarf1targetinggdipeptidesaspotentialagentsagainstheadandnecksquamouscellcarcinoma